Ayurveda as an alternative Medicine for SARS-CoV

Abstract

The goal of this study was to look at the clinical evidence for complementary and alternative medicine treatments for major depressive disorder. The phrase depressive disorder was combined with St John’s wort, S-adenosylmethionine (SAM-e), exercise, acupuncture, omega-3 fatty acids, and folate in a PubMed search from January 1966 to February 2010. Only relevant human trials were selected. COVID-19, the current global health emergency, is not the first-time coronaviruses have posed a threat to the human world, reducing our population by thousands. Previously, In SARS-CoV 2003 andMERS-CoV in 2013 prompted epidemics. Four months into its creation, it has since affected 1,995,983 people and killed dozens of over 131,037 people worldwide, yet we do not have any specific treatment and management is mainly empirical. Given the similarities in origin, genome sequencing, pathogenesis, and epidemiology between SARS-CoV and SARS-CoV-2, we can use the research done for SARS-CoV as a guide in developing a successful action plan for SARS-CoV-2. Here unlimited research and according to studies the use and effect of various phytochemical compounds in treatment also now, the idea has been implemented, and in-silico screening for different natural plant products has been performed in order to identify a viable candidate substance. One such example is of curcumin, a secondary metabolite of turmeric, which is found to Complementary Medicine Plants have been the source of countless compounds with medicinal properties that have led to drug discovery since the dawn of time. Since ancient times, Indian Ayurveda, Traditional Chinese Medicine Literature, and ancient Egyptian Ebers Papyrus have all described various plants and herbs with medicinal properties that are still used today. More than a few more proteins are encrypted by viral diseases. Most of these amino acids include: required for viral replication and entry. The well-studied proteins so far are papain-like protease (PLpro), 3C-like protease (3CLpro), and spike protein. These three proteins all appear to be promising candidates for therapeutic development